Latest publications for May 2024 from Cochrane Infectious Diseases Group

30 May 2024

During May 2024, the CIDG contributed to two new Cochrane protocols in Issue 5, 2024 of the Cochrane Database of Systematic Reviews.

New Cochrane protocols

  • Olbrich L, Kay AW, Bjerrum S, Yang B, Åhsberg J, Nathavitharana RR, Lundh A, Shah M, Jaganath D. Parallel use of low‐complexity automated nucleic acid amplification tests on respiratory samples and stool with or without lateral flow lipoarabinomannan assays to detect pulmonary tuberculosis disease in children. Cochrane Database of Systematic Reviews 2024, Issue 5. Art. No.: CD016071. DOI: 10.1002/14651858.CD016071 
  • Bjerrum S, Yang B, Åhsberg J, Nathavitharana RR, Olbrich L, Jaganath D, Kay AW, Lundh A, Shah M. Parallel use of low‐complexity automated nucleic acid amplification tests and lateral flow urine lipoarabinomannan assays to detect tuberculosis disease in adults and adolescents living with HIV. Cochrane Database of Systematic Reviews 2024, Issue 5. Art. No.: CD016070. DOI:10.1002/14651858.CD016070  

Other publications 

  • Chaplin M, Dwan K. Intention-to-treat analyses and missing outcome data: a tutorial. Cochrane Evidence Synthesis and Methods (2024): 2(5): e12075. DOI: 10.1002/cesm.12075

Other items

  • IDG Research Associate Dr Rebecca Kuehn recently attended an Advanced GRADE Methodology workshop. Read more about it here.

 

Do continue to check our CIDG and READ-It websites for updates, and follow us on X .

The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise. The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals.